A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

Inclusion Criteria: * Non-smoker * Medically healthy * 32.0 \>= BMI \>= 18.5 kg/m\^2 * Weight \>= 50 kg for males * Weight \>= 45 kg for females * For a female of childbearing potential: either be sexually inactive for 14 days prior to the first dose and throughout the study or be using an acceptable birth control method as dictated by the study * Willing to comply with protocol and understands study procedures outlined in the ICF Exclusion Criteria: * Subject is mentally or legally incapacitated or has significant emotional problems * History or presence of medical or psychiatric disease * History of any illness that might confound the results of the study * History or presence of alcoholism or drug abuse * History or presence of hypersensitivity or idiosyncratic reaction the the study drug excipient * History or presence of lactose intolerance * Pregnant or lactating females * Seated blood pressure less than 90/40 mmHg or greater than 140/90 mmHg * Seated heart rate lower than 40 bpm or higher than 99 bpm * Unable to refrain from or anticipates the use of any drug * Diet incompatible with the on-study diet * Donation of blood or significant blood loss within 56 days prior to the first study dose * Participation in another clinical trial within 28 days prior to the first study dose